Skip to main content

Table 2 Patient characteristics

From: HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia

Patient

Age

(years)

Sex

WPSS risk group

Blood cells

Primitive cells

(%)

Auer rod

No. of monocytes

Patient 3

61

Male

High

Decrease

18

Positive

0.8 × 109/L

Patient 7

65

Male

Very high

Decrease

13

Positive

0.7 × 109/L

Patient 1

63

Male

Very high

Decrease

15

Positive

0.4×109/L